BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18755853)

  • 21. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
    Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
    Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
    Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
    Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
    Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
    Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
    Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
    Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
    Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
    Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
    Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperparathyroidism-jaw tumor syndrome: a case report.
    Rekik N; Ben Naceur B; Mnif M; Mnif F; Mnif H; Boudawara T; Abid M
    Ann Endocrinol (Paris); 2010 Mar; 71(2):121-6. PubMed ID: 19942209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
    Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
    Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
    Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
    Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
    Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
    J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
    Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
    Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
    Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
    Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
    Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
    Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.